Search - tctmd.com

Displaying 261 - 280 of 701

Sort: Relevancy | Date

Presentation TCT 2018

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

Presenter: Alexandra J. Lansky, Axel Linke, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

Presenter: Alain G. Cribier, Helene Eltchaninoff, Herbert Kroon

September 21, 2018

Presentation TCT 2018

Carotid Artery Disease Technical Considerations: Embolic Protection Options and Selection

Presenter: Aman B. Patel, Kenneth Rosenfield, Alexander A. Khalessi

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

Presenter: Tamim Nazif

September 21, 2018

Presentation TCT 2018

Full Body Embolic Protection During TAVR (Filterlex)

Presenter: Giora Weisz

September 21, 2018

Presentation TCT 2018

Atherotomy (Cutting, Scoring, Lithotrispy), Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Robert T. Pyo

September 21, 2018

News Conference News ESC 2018

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Yael L. Maxwell

September 06, 2018

News Conference News ESC 2018

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

L.A. McKeown

September 04, 2018

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

Todd Neale

August 26, 2018

News Daily News

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

Todd Neale

August 13, 2018

News Industry News

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

July 24, 2018

News Daily News

Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban

Todd Neale

July 24, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

Presentation The Structural Heart Disease Summit 2018

Full Body Embolic Protection During TAVR: The FILTEREX System

Presenter: Juan F. Granada, Martin B. Leon, Giora Weisz

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

Advertisement

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

TCT-98: Early Clinical Impact of Cerebral Embolic Protection With Transcatheter Aortic Valve Replacement, a Multicenter Study in the Netherlands

Carotid Artery Disease Technical Considerations: Embolic Protection Options and Selection

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Early Experiences with the New TriGUARD 3 Embolic Protection Device During TAVR: The REFLECT Trial

Full Body Embolic Protection During TAVR (Filterlex)

Atherotomy (Cutting, Scoring, Lithotrispy), Atherectomy (Rotational, Orbital, Laser), and Embolic Protection

TAVR Debris Captured by Sentinel Embolic Protection Differs by Valve Type

Oral Antibiotics for Endocarditis Allow for Safe, Early Hospital Discharge

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks

Boston Scientific Announces Agreement to Acquire Claret Medical, Inc.

Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Full Body Embolic Protection During TAVR: The FILTEREX System

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

NO: The Data Are Weak and the Costs Are Prohibitive!

YES: Review of ALL the Data and Common Sense Tell the Story!

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content